Related references
Note: Only part of the references are listed.The safety and effectiveness of stereotactic body radiotherapy for central versus ultracentral lung tumors
Joe H. Chang et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Risk-Adapted Lung SBRT for Central and UltraCentral Tumors
A. Lenglet et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy: A Single Institutional Experience
V. Yau et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Safety of Stereotactic Body Radiotherapy for Central, Ultracentral, and Paramediastinal Lung Tumors
Megan Daly et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
The Nordic HILUS-Trial - First Report of a Phase II Trial of SBRT of Centrally Located Lung Tumors
Karin Lindberg et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Assessment of Radiobiological α/β Ratio in Lung Cancer and Fibroblast Cell Lines Using Viability Assays
Ilias V. Karagounis et al.
IN VIVO (2017)
Bevacizumab for non-small-cell lung cancer: A nested case control study of risk factors for hemoptysis
Koichi Goto et al.
CANCER SCIENCE (2016)
Outcomes of Hypofractionated High-Dose Radiotherapy in Poor-Risk Patients with Ultracentral Non-Small Cell Lung Cancer
Hilal Tekatli et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
For non-small cell lung cancer with T3 (central) disease, sleeve lobectomy or pneumonectomy?
Qian-Li Ma et al.
JOURNAL OF THORACIC DISEASE (2016)
Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree
Justin M. Haseltine et al.
PRACTICAL RADIATION ONCOLOGY (2016)
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
Jeffrey D. Bradley et al.
LANCET ONCOLOGY (2015)
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
Joe Y. Chang et al.
LANCET ONCOLOGY (2015)
Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors
Aadel A. Chaudhuri et al.
LUNG CANCER (2015)
The Tumor Radiobiology of SRS and SBRT: Are More Than the 5 Rs Involved?
J. Martin Brown et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
STEREOTACTIC BODY RADIOTHERAPY FOR MEDICALLY INOPERABLE LUNG CANCER: PROSPECTIVE, SINGLE-CENTER STUDY OF 108 CONSECUTIVE PATIENTS
Mojgan Taremi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Stereotactic Body Radiotherapy for Central Lung Tumors
Bryan P. Rowe et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Central-Airway Necrosis after Stereotactic Body-Radiation Therapy
Michael N. Corradetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Determining the appropriate sleeve lobectomy versus pneumonectomy ratio in central non-small cell lung cancer patients: an audit of an aggressive policy of pneumonectomy avoidance
Abel Gomez-Caro et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2011)
PROSPECTIVE, RISK-ADAPTED STRATEGY OF STEREOTACTIC BODY RADIOTHERAPY FOR EARLY-STAGE NON-SMALL-CELL LUNG CANCER: RESULTS OF A PHASE II TRIAL
Samuel Bral et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR OPERABLE STAGE I NON SMALL-CELL LUNG CANCER: CAN SBRT BE COMPARABLE TO SURGERY?
Hiroshi Onishi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Outcomes of Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Lung Cancer
Cornelis J. A. Haasbeek et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
STEREOTACTIC BODY RADIATION THERAPY FOR EARLY-STAGE NON-SMALL-CELL LUNG CARCINOMA: FOUR-YEAR RESULTS OF A PROSPECTIVE PHASE II STUDY
Achilles J. Fakiris et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
STEREOTACTIC BODY RADIATION THERAPY IN CENTRALLY AND SUPERIORLY LOCATED STAGE I OR ISOLATED RECURRENT NON-SMALL-CELL LUNG CANCER
Joe Y. Chang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study
Hiroshi Onishi et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer
Robert Timmerman et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer
Tingyi Xia et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
S Duval et al.
BIOMETRICS (2000)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
